SEARCH

SEARCH BY CITATION

References

  • 1
    Yoon PW, Gillespie CD, George MG, Wall HK. Control of hypertension among adults - national health and nutrition examination survey, United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2012;61:1925.
  • 2
    Centers for Disease Control (CDC). Vital signs: prevalence, treatment, and control of hypertension – United States, 1999–2002 and 2005–2008. MMWR Morb Mortal Wkly Rep. 2011;60:103108.
  • 3
    Wang JT, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112:16511662.
  • 4
    Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594599.
  • 5
    Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:20432050.
  • 6
    Shelley D, Tseng TY, Andrews H, et al. Predictors of blood pressure control among hypertensive in community health centers. Am J Hypertens. 2011;24:13181323.
  • 7
    Egan BM, Basile JN. Controlling blood pressure in 50% of all hypertensive patients. J Investig Med. 2003;51:373385.
  • 8
    US Department of Health and Human Services. Healthy People 2010. Understanding and Improving Health, 2nd ed. Washington, DC: US Government Printing Office; November 2000.
  • 9
    Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:12331241.
  • 10
    Wei M, Mitchell BD, Haffner SM, Stern MP. Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol. 1996;144:10581065.
  • 11
    Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6:497502.
  • 12
    Thomas AJ, Eberly LE, Smith GD, et al. Race/ethnicity, income, major risk factors, and cardiovascular disease mortality. Am J Public Health. 2005;95:14171423.
  • 13
    Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2e220.
  • 14
    Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:15851592.
  • 15
    Darnell JS. Free clinics in the United States: a nationwide survey. Arch Intern Med. 2010;170:946953.
  • 16
    US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Primary Health Care. Health Centers: America's Primary Care Safety Net, Reflections on Success, 2002–2007. Rockville, MD; June 2008.
  • 17
    Quality Incentives for Federally Qualified Health Centers, Rural Health Clinics and Free Clinics: A Report to Congress. Washington, DC: Department of Health Policy School of Public Health and Health Service; 2012.
  • 18
    Dievler A, Giovannini T. Community health centers: promise and performance. Med Care Res Rev. 1998;55:405431.
  • 19
    Politzer RM, Yoon J, Shi L, et al. Inequality in America: the contribution of health centers in reducing and eliminating disparities in access to care. Med Care Res Rev. 2001;58:234248.
  • 20
    Gale J, Coburn A. The Characteristics and Roles of Rural Health Clinics in the United States: A Chartbook. Portland, ME: University of Southern Maine, Muskie School of Public Service, Maine Rural Health Research Center; 2003.
  • 21
    Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
  • 22
    Rabi DM, Edwards AL, Southern DA, et al. Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res. 2006;6:124130.
  • 23
    Agardh E, Allebeck P, Hallqvist J, et al. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40:804818.
  • 24
    Duggirala MK, Cuddihy RM, Cuddihy MT, et al. Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics. Am J Hypertens. 2005;18:833838.
  • 25
    Borzecki AM, Wong AT, Hickey EC, et al. Hypertension control: how well are we doing? Arch Intern Med. 2003;163:27052711.
  • 26
    Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380:601610.
  • 27
    Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891897.
  • 28
    2010 Annual Report: Ingham County Health Department. http://hd.ingham.org/Portals/HD/Home/Documents/Publications/2010%20Annual%20Report%20Web%20Version.pdf. Accessed July 18, 2012.
  • 29
    Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC-7 report. JAMA. 2003;289:25602572.
  • 30
    SAS Institute Inc. Base SAS 9.2 Procedures Guide. Cary, NC; 2009.
  • 31
    Ornstein SM, Nietert PJ, Dickerson LM. Hypertension management and control in primary care: a study of 20 practices in 14 states. Pharmacotherapy. 2004;24:500507.
  • 32
    DeVore AD, Sorrentino M, Arnsdorf MF, et al. Predictors of hypertension control in a diverse general cardiology practice. J Clin Hypertens (Greenwich). Aug 2010;12:570577.
  • 33
    Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens. 2002;4:393404.
  • 34
    Olomu A, Gourineni V, Pandya N, et al. Office-Guidelines Applied in Practice (Office-GAP) Program in a federally qualified health center increased patient knowledge and medication use. Circulation. 2011;124:A12338.
  • 35
    Hicks L, Shaykevich S, Bates D, Ayanian J. Determinants of racial/ethnic differences in blood pressure management among hypertensive patients. BMC Cardiovasc Disord. 2005;5:16.
  • 36
    Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479486.
  • 37
    Hicks LS, Fairchild DG, Horng MS, et al. Determinants of JNC VI guideline adherence, intensity of drug therapy,and blood pressure control by race and ethnicity. Hypertension. 2004;44:429434.
  • 38
    Ong KL, Tso AW, Lam KS, Cheung BM. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51:11421148.
  • 39
    Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med. 1997;12:714.
  • 40
    Stockwell DH, Madhavan S, Cohen H, et al. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:17681774.
  • 41
    Majernick TG, Zacker C, Madden NA, et al. Correlates of hypertension control in a primary care setting. Am J Hypertens. 2004;17:915920.
  • 42
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199206.
  • 43
    Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:11991208.
  • 44
    Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:70.e970.e15.
  • 45
    Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical activity, and Metabolism. Circulation. 2006;113:898918.
  • 46
    Halperin RO, Gaziano JM, Sesso HD. Smoking and the risk of incident hypertension in middle-aged and older men. Am J Hypertens. 2008;21:148152.
  • 47
    Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355:253259.
  • 48
    Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA. Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes. Diabetes Care. 2004;27:13301334.
  • 49
    Barron HV, Michaels AD, Maynard C, et al. Use of antiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol. 1998;32:360367.